#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1072303	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 28 after infection	Candida albicans	2		organism-based format	Scientific Literature
2.	ALA1072304	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 21 after infection	Candida albicans	2		organism-based format	Scientific Literature
3.	ALA1072305	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 14 after infection	Candida albicans	2		organism-based format	Scientific Literature
4.	ALA1072306	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 7 after infection	Candida albicans	2		organism-based format	Scientific Literature
5.	ALA1072307	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 5 after infection	Candida albicans	2		organism-based format	Scientific Literature
6.	ALA1072308	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 24 hrs after fungal infection measured on day 2 after infection	Candida albicans	2		organism-based format	Scientific Literature
7.	ALA1072309	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 1 hr after fungal infection measured on day 1 after infection	Candida albicans	2		organism-based format	Scientific Literature
8.	ALA1072310	F	Antifungal activity against pharmacoresistant Candida albicans AIDS68 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 1 hr after fungal infection measured within 1 day of infection	Candida albicans	2		organism-based format	Scientific Literature
9.	ALA1072319	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 28 after infection	Candida albicans	2		organism-based format	Scientific Literature
10.	ALA1072320	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 21 after infection	Candida albicans	2		organism-based format	Scientific Literature
11.	ALA1072321	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 14 after infection	Candida albicans	2		organism-based format	Scientific Literature
12.	ALA1072961	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 7 after infection	Candida albicans	2		organism-based format	Scientific Literature
13.	ALA1072962	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 48 hrs after fungal infection measured on day 5 after infection	Candida albicans	2		organism-based format	Scientific Literature
14.	ALA1072963	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 24 hrs after fungal infection measured on day 2 after infection	Candida albicans	2		organism-based format	Scientific Literature
15.	ALA1074245	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 1 hr after fungal infection measured on day 1 after infection	Candida albicans	2		organism-based format	Scientific Literature
16.	ALA1074246	F	Antifungal activity against Candida albicans SA40 infected in Wistar rat estrogen-dependent fungal vaginitis model assessed as fungal burden at 10 uM administered intravaginally 1 hr after fungal infection measured within 1 day of infection	Candida albicans	2		organism-based format	Scientific Literature
17.	ALA1074247	B	Inhibition of Candida albicans SAP2 at 0.2 uM by spectrophotometry relative to pepstatin A	Candida albicans	1		single protein format	Scientific Literature
18.	ALA1074248	B	Inhibition of Candida albicans SAP2 at 0.02 uM by spectrophotometry relative to pepstatin A	Candida albicans	2		single protein format	Scientific Literature
19.	ALA1074249	B	Inhibition of Candida albicans SAP2 at 20 uM by spectrophotometry relative to pepstatin A	Candida albicans	21		single protein format	Scientific Literature
20.	ALA1074250	B	Inhibition of Candida albicans SAP2 at 2 uM by spectrophotometry relative to pepstatin A	Candida albicans	2		single protein format	Scientific Literature